COMPANY

Equator Therapeutics

Keywords: metabolic

Location: Saint Louis, MO · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $423K (SBIR Phase I 1R43DK146576-01A1, new, notice Aug 27, 2026). NIH RePORTER 1R43DK146576-01A1 (Aug 27, 2026)
Evidence (1 event)
- Aug 27, 2026 · NIH RePORTER 1R43DK146576-01A1
  Organization: EQUATOR THERAPEUTICS, INC.; City/State: Saint Louis, MO; Project number: 1R43DK146576-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-27; FY total cost (award amount): 422785; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Partial Agonism of Mitochondrial Thermogenesis for the Safe Stimulation of Energy Expenditure; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 27, 2026 Grant Government grant — SBIR: $422,785 (annual award, as published), announced Aug 27, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 20, 2025 Grant Government grant — SBIR: $1.57M (annual award, as published), announced Aug 20, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗

Last 2 years.

Aug 27, 2026 Government grant — SBIR: $422,785 (annual award, as published), announced Aug 27, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 20, 2025 Government grant — SBIR: $1.57M (annual award, as published), announced Aug 20, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗